Purple Biotech (PPBT) Intangibles (2017 - 2026)

Purple Biotech (PPBT) has 10 years of Intangibles data on file, last reported at $7.4 million in Q1 2026.

• On a quarterly basis, Intangibles fell 73.57% year-over-year to $7.4 million in Q1 2026; TTM through Mar 2026 was $7.4 million, a 73.57% decrease from a year earlier, with the FY2025 full-year figure at $7.4 million, down 73.57% from the prior year.
• Intangibles for Q1 2026 stood at $7.4 million, roughly flat from $7.4 million in the prior quarter.
• Over the last five years, Intangibles for PPBT reached as high as $28.0 million in Q1 2023 and fell as low as -$202000.0 in Q4 2022.
• Historically, Intangibles has averaged $22.6 million across 5 years, with a median of $27.8 million in 2024.
• Across the five-year window, Intangibles plunged 100.99% in 2022 and soared 13983.17% in 2023, its largest moves.
• Year by year, Intangibles stood at -$202000.0 in 2022, then surged by 13983.17% to $28.0 million in 2023, then slipped by 0.72% to $27.8 million in 2024, then sank by 73.57% to $7.4 million in 2025, then changed by 0.0% to $7.4 million in 2026.
• Per Business Quant data, the three most recent Intangibles figures were $7.4 million in Q1 2026, $7.4 million in Q4 2025, and $27.8 million in Q3 2025.